Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/Akt pathway

Molecular Cell

Volumn 10, Issue 1, 2002, Pages 151-162

  Manning, Brendan D ^a,b   Tee, Andrew R ^a   Logsdon, M Nicole ^b   Blenis, John ^a   Cantley, Lewis C ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; PROTEIN S6K1; TUBERIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PROTEIN PHOSPHORYLATION; TUMOR CELL LINE;

EID: 0036342294     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(02)00568-3     Document Type: Article

References (55)

1. Molecular basis for the substrate specificity of protein kinase B; Comparison with MAPKAP kinase-1 and p70 S6 kinase
2. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B
3. A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt
4. Ten years of protein kinase B signalling: A hard Akt to follow
5. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
6. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer
7. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
8. The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1
9. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases
10. PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase
11. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
12. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs
13. Mammalian TOR: A homeostatic ATP sensor
14. Phosphatidic acid-mediated mitogenic activation of mTOR signaling
15. Substrate recognition determinants of the mitogen-activated 70K S6 kinase from rat liver
16. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
17. Direct regulation of the AKT proto-oncogene product by phosphatidylinositol-3,4-bisphosphate
18. TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth
19. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism
20. Cellular function of phosphoinositide 3-kinases: Implications for development, immunity, homeostasis, and cancer
21. Construction and characterization of a conditionally active version of the serine/threonine kinase Akt
22. A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in TSC1 null cells
23. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate
24. Coordinate regulation of translation by the PI 3-kinase and mTOR pathways
25. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function
26. Mammalian target of rapamycin is a direct target for protein kinase B: Identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation
27. Characterization of the cytosolic tuberin-hamartin complex
28. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR
29. Determination of the specific substrate sequence motifs of protein kinase C isozymes
30. Use of peptide and protein library screening to define optimal substrate motifs for Akt/PKB
31. Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway
32. Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size
33. S6K by PDK1
34. DS6K-regulated cell growth is dPKB/dPI(3)K-independent, but requires dPDK1
35. Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway
36. The role of phosphoinositide 3-kinase lipid products in cell function
37. P70 S6 kinase is regulated by protein kinase Cz and participates in a phosphoinositide 3-kinase-regulated signalling complex
38. Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway
39. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells
40. The use of peptide library for the determination of kinase peptide substrates
41. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B
42. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5-triphosphate and Akt/protein kinase B signaling pathway
43. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation
44. Protein kinases as mediators of phosphoinositide 3-kinase signaling
45. The PI3K-PDK1 connection: More than just a road to PKB
46. Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB
47. PI 3-kinase, mTOR, protein synthesis and cancer
48. Multiple independent inputs are required for activation of the p70 S6 kinase
49. Regulation of the p70 S6 kinase by phosphorylation in vivo. Analysis using site-specific anti-phosphopeptide antibodies
50. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression
51. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity
52. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis
53. Mapping specificity determinants for protein-protein association using protein fusions and random peptide libraries
54. A motif-based profile scanning approach for genome-wide prediction of signaling pathways